Structure-based discovery of thiosemicarbazones as SARS-CoV-2 main protease inhibitors.
Future Med Chem
; 15(11): 959-985, 2023 06.
Article
in En
| MEDLINE
| ID: mdl-37435731
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Thiosemicarbazones
/
COVID-19
Limits:
Humans
Language:
En
Year:
2023
Type:
Article